Abstract
Dysregulated CD4 T cell responses are causally linked to autoimmune and chronic inflammatory disorders, yet the cellular attributes responsible for maintaining the disease remain poorly understood. Herein, we identify a discrete population of effector CD4 T cells that is able to both sustain and confer intestinal inflammation. This subset of pathogenic CD4 T cells possesses a unique gene signature consistent with self-renewing T cells and hematopoietic progenitor cells, exhibits enhanced survival, and continually seeds the terminally differentiated IFNγ-producing cells in the inflamed intestine. Mechanistically, this population selectively expresses the glycosyltransferase ST6Gal-I, which is required for optimal expression of the stemness-associated molecule TCF1 by effector CD4 T cells. Our findings indicate that the chronicity of T cell–mediated inflammation is perpetuated by specific effector CD4 T cells with stem-like properties.
Cite
CITATION STYLE
Shin, B., Kress, R. L., Kramer, P. A., Darley‑Usmar, V. M., Bellis, S. L., & Harrington, L. E. (2018). Effector CD4 T cells with progenitor potential mediate chronic intestinal inflammation. Journal of Experimental Medicine, 215(7), 1803–1812. https://doi.org/10.1084/jem.20172335
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.